A nursing team from Tufts Medical Center discusses their case presentation on the use of Reiki in a patient with cGVHD. Concerns about recurrence and the development of second primary breast cancers are particularly pressing in these patients. New research shows why it's essential for oncology nurses to understand evolving axillary management practices. The organization provides educational materials, a peer-to-peer program, a financial assistance program, and more. Matthew Farren, BSN, RN, speaks about the research that he presented at the 50th Annual ONS Congress. Melissa Cooke, MS. CCC-SLP, of the Head & Neck Cancer Alliance, reflects on the importance of the annual observance. Veronica Brady, PhD, FNP-BC, BC-ADM, CDCES, FADCES, shares insights from her ONS Congress presentation on the topic. NCCN guidelines recommend radiation therapy for early-stage breast cancer, but social factors can limit patient adherence. Suboptimal adherence to oral anticancer agents can lead to reduced therapeutic benefits and increased risk of mortality. Josie Montegaard, NP, shares how nurses can help patients mitigate and manage negative CLL treatment side effects. Learn what nurses should know about emerging research that challenges long-standing treatment norms. A study presented at the NCCN Annual Conference shed light on the perspectives of patients and healthcare professionals. A team of researchers from China explored psychologic factors that play a role in the mastectomy decision-making process. Researchers explored factors that affect decision regret, such as clinical characteristics and decision-making experiences. Learn how improved communication and education about sexuality can improve prostate cancer treatment for patients. Josie Montegaard, NP, discusses key guidelines, criteria, and the need for flexibility when initiating treatment for CLL. Researchers evaluated the effectiveness of three preoperative and postoperative models of care after radical gastrectomy. New research suggests that screening guidelines should be refined to account for asymptomatic brain metastases. A recent survey provides key insights into patient experiences with MIBC treatment and diagnosis over the past decade. The study evaluated the safety and efficacy of ruxolitinib for treating chronic graft-versus-host disease after allo-HSCT.